Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sutherland

Showing results (841-850 of 999) with videos related to

Pageof 100
Sort By:
Plos One|January 28, 2016
Priority Questions and Horizon Scanning for Conservation: A Comparative StudySalit Kark, William J Sutherland, Uri Shanas, et al.
Leukemia & Lymphoma|August 23, 2006
Leukocyte count as a predictor of death during remission induction in acute myeloid leukemiaM J Greenwood, M D Seftel, C Richardson, et al.
The Journal of Infectious Diseases|August 16, 2013
Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrenceKhalid B Beshir, Colin J Sutherland, Patrick Sawa, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 18, 2015
Diverse phenotypic consequences of mutations affecting the C-terminus of FLNAMargriet van Kogelenberg, Alice R Clark, Zandra Jenkins, et al.
Leukemia & Lymphoma|December 24, 2011
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapyAdisak Tantiworawit, Maryse M Power, Michael J Barnett, et al.
Bone Marrow Transplantation|July 15, 2009
Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimensY R Abou-Mourad, B C Lau, M J Barnett, et al.
Bone Marrow Transplantation|October 17, 2003
Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysisD L Forrest, T J Nevill, S C Naiman, et al.
Mbio|February 27, 2020
The <i>Plasmodium falciparum</i> Artemisinin Susceptibility-Associated AP-2 Adaptin μ Subunit is Clathrin Independent and Essential for Schizont MaturationRyan C Henrici, Rachel L Edwards, Martin Zoltner, et al.
Malaria Journal|September 8, 2007
World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malariaChristopher V Plowe, Cally Roper, John W Barnwell, et al.
Scientific Reports|September 5, 2020
A global biophysical typology of mangroves and its relevance for ecosystem structure and deforestationThomas A Worthington, Philine S E Zu Ermgassen, Daniel A Friess, et al.
Pageof 100

Showing results (841-850 of 999) with videos related to

Sort By:
Pageof 100
Plos One|January 28, 2016
Priority Questions and Horizon Scanning for Conservation: A Comparative StudySalit Kark, William J Sutherland, Uri Shanas, et al.
Leukemia & Lymphoma|August 23, 2006
Leukocyte count as a predictor of death during remission induction in acute myeloid leukemiaM J Greenwood, M D Seftel, C Richardson, et al.
The Journal of Infectious Diseases|August 16, 2013
Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrenceKhalid B Beshir, Colin J Sutherland, Patrick Sawa, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 18, 2015
Diverse phenotypic consequences of mutations affecting the C-terminus of FLNAMargriet van Kogelenberg, Alice R Clark, Zandra Jenkins, et al.
Leukemia & Lymphoma|December 24, 2011
Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapyAdisak Tantiworawit, Maryse M Power, Michael J Barnett, et al.
Bone Marrow Transplantation|July 15, 2009
Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimensY R Abou-Mourad, B C Lau, M J Barnett, et al.
Bone Marrow Transplantation|October 17, 2003
Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysisD L Forrest, T J Nevill, S C Naiman, et al.
Mbio|February 27, 2020
The <i>Plasmodium falciparum</i> Artemisinin Susceptibility-Associated AP-2 Adaptin μ Subunit is Clathrin Independent and Essential for Schizont MaturationRyan C Henrici, Rachel L Edwards, Martin Zoltner, et al.
Malaria Journal|September 8, 2007
World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malariaChristopher V Plowe, Cally Roper, John W Barnwell, et al.
Scientific Reports|September 5, 2020
A global biophysical typology of mangroves and its relevance for ecosystem structure and deforestationThomas A Worthington, Philine S E Zu Ermgassen, Daniel A Friess, et al.
Pageof 100